TY  - RPRT
TI  - NIH's dedicated K23 trial pathway was associated with more K-trial leadership but no detectable gain in new trials
AU  - Wang, H.
AU  - Fu, H.
AU  - Tian, Z.
PY  - 2026
DO  - 10.64898/2026.10.09.758109
UR  - https://www.biorxiv.org/content/10.64898/2026.10.09.758109v1
ID  - 10.64898/2026.10.09.758109
ER  -